Pricing Log in Create free account

Alps Group Inc. (ALPS) vs MiNK Therapeutics, Inc. (INKT)

Alps Group Inc. and MiNK Therapeutics, Inc. are both Biotechnology companies. Alps Group Inc. and MiNK Therapeutics, Inc. are of similar size ($52.3M and $51.3M). Across the 7 metrics below, MiNK Therapeutics, Inc. leads on 4 and Alps Group Inc. on 3.

Valuation

Metric ALPS INKT Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales n/m n/m 9.02
Earnings yield (229.73%) (23.19%) (32.88%)
Free cash flow yield (84.65%) (13.28%) (23.13%)

Profitability

Metric ALPS INKT Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 25.50% 57.94% (51.96%)
Return on assets 0.00% (187.78%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALPS INKT Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 21.95% (2.45%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALPS INKT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.04 1.23 4.97
Net debt to EBITDA 0.00 1.07 1.01

Dividend

Metric ALPS INKT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ALPS INKT Biotechnology median
Market cap 52.30m 51.28m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack